Biomarker Discovery Platform

ProteoMediX will employ quantitative proteomic technologies for the detection and validation of protein biomarkers in tissue and serum that reflect the physiological status of specific organs. Due to its high sensitivity and high-throughput, mass spectrometry (MS) is the method of choice for the identification and accurate quantification of the proteins contained in complex sample mixtures. ProteoMediX uses a rigorously tested and validated protein biomarker discovery and validation platform.